Hepatic resection combined with radiofrequency ablation for initially unresectable colorectal liver metastases after effective chemotherapy is a safe procedure with a low incidence of local recurrence

International Journal of Clinical Oncology

Volumn 18, Issue 5, 2013, Pages 847-855

  Mima, Kosuke ^a   Beppu, Toru ^a   Chikamoto, Akira ^a   Miyamoto, Yuji ^a   Nakagawa, Shigeki ^a   Kuroki, Hideyuki ^a   Okabe, Hirohisa ^a   Hayashi, Hiromitsu ^a   Sakamoto, Yasuo ^a   Watanabe, Masayuki ^a   Kikuchi, Ken ^b   Baba, Hideo ^a  

^a KUMAMOTO UNIVERSITY   (Japan)

^b KUMAMOTO UNIVERSITY   (Japan)

Author keywords

Chemotherapy; Colorectal liver metastases (CRLM); FOLFOX; Hepatic resection combined with RFA; Radiofrequency ablation (RFA)

Indexed keywords

BEVACIZUMAB; CA 19-9 ANTIGEN; CARCINOEMBRYONIC ANTIGEN; CETUXIMAB; FLUOROURACIL; FOLINIC ACID; IRINOTECAN; OXALIPLATIN;

ADULT; CANCER COMBINATION CHEMOTHERAPY; CANCER MORTALITY; CANCER RECURRENCE; CANCER SURVIVAL; CLINICAL EFFECTIVENESS; COLORECTAL LIVER METASTASIS; CONFERENCE PAPER; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; FEMALE; HUMAN; INCIDENCE; LIVER RESECTION; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MULTIPLE CYCLE TREATMENT; NEEDLE; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PATIENT SAFETY; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; PROSPECTIVE STUDY; RADIOFREQUENCY ABLATION; SURGICAL MORTALITY; SURVIVAL RATE;

AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; COLORECTAL NEOPLASMS; COMBINED MODALITY THERAPY; DISEASE-FREE SURVIVAL; DRUG THERAPY; FEMALE; FLUOROURACIL; HEPATECTOMY; HUMANS; LEUCOVORIN; LIVER NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; ORGANOPLATINUM COMPOUNDS; TREATMENT OUTCOME;

EID: 84886094218     PISSN: 13419625     EISSN: 14377772     Source Type: Journal    
DOI: 10.1007/s10147-012-0471-z     Document Type: Conference Paper

References (37)

1. Siegel R, Naishadham D, Jemal A (2012) Cancer statistics, 2012. CA Cancer J Clin 62:10-29
2. Kobayashi H, Mochizuki H, Sugihara K et al (2007) Characteristics of recurrence and surveillance tools after curative resection for colorectal cancer: a multicenter study. Surgery 141:67-75
3. McArdle CS, Hole DJ (2002) Outcome following surgery for colorectal cancer. Br Med Bull 64:119-125
4. Stangl R, Altendorf-Hofmann A, Charnley RM et al (1994) Factors influencing the natural history of colorectal liver metastases. Lancet 343:1405-1410
5. Simmonds PC, Primrose JN, Colquitt JL et al (2006) Surgical resection of hepatic metastases from colorectal cancer: a systematic review of published studies. Br J Cancer 94:982-999
6. Minagawa M, Makuuchi M, Torzilli G et al (2000) Extension of the frontiers of surgical indications in the treatment of liver metastases from colorectal cancer: long-term results. Ann Surg 231:487-499
7. Kokudo N, Miki Y, Sugai S et al (2002) Genetic and histological assessment of surgical margins in resected liver metastases from colorectal carcinoma: minimum surgical margins for successful resection. Arch Surg 137:833-840
8. Adam R, Delvart V, Pascal G, et al (2004) Rescue surgery for unresectable colorectal liver metastases downstaged by chemotherapy: a model to predict long-term survival. Ann Surg 240:644-657 (discussion 657-648)
9. de Gramont A, Figer A, Seymour M et al (2000) Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer. J Clin Oncol 18:2938-2947
10. Giacchetti S, Perpoint B, Zidani R et al (2000) Phase III multicenter randomized trial of oxaliplatin added to chronomodulated fluorouracil-leucovorin as first-line treatment of metastatic colorectal cancer. J Clin Oncol 18:136-147
11. Goldberg RM, Sargent DJ, Morton RF et al (2004) A randomized controlled trial of fluorouracil plus leucovorin, irinotecan, and oxaliplatin combinations in patients with previously untreated metastatic colorectal cancer. J Clin Oncol 22:23-30
12. Grothey A, Sargent D, Goldberg RM et al (2004) Survival of patients with advanced colorectal cancer improves with the availability of fluorouracil-leucovorin, irinotecan, and oxaliplatin in the course of treatment. J Clin Oncol 22:1209-1214
13. Falcone A, Ricci S, Brunetti I et al (2007) Phase III trial of infusional fluorouracil, leucovorin, oxaliplatin, and irinotecan (FOLFOXIRI) compared with infusional fluorouracil, leucovorin, and irinotecan (FOLFIRI) as first-line treatment for metastatic colorectal cancer: the Gruppo Oncologico Nord Ovest. J Clin Oncol 25:1670-1676
14. Alberts SR, Horvath WL, Sternfeld WC et al (2005) Oxaliplatin, fluorouracil, and leucovorin for patients with unresectable liver-only metastases from colorectal cancer: a North Central Cancer Treatment Group phase II study. J Clin Oncol 23:9243-9249
15. Skof E, Rebersek M, Hlebanja Z et al (2009) Capecitabine plus Irinotecan (XELIRI regimen) compared to 5-FU/LV plus Irinotecan (FOLFIRI regimen) as neoadjuvant treatment for patients with unresectable liver-only metastases of metastatic colorectal cancer: a randomised prospective phase II trial. BMC Cancer 9:120
16. Van Cutsem E, Rivera F, Berry S et al (2009) Safety and efficacy of first-line bevacizumab with FOLFOX, XELOX, FOLFIRI and fluoropyrimidines in metastatic colorectal cancer: the BEAT study. Ann Oncol 20:1842-1847
17. Folprecht G, Gruenberger T, Bechstein WO et al (2010) Tumour response and secondary resectability of colorectal liver metastases following neoadjuvant chemotherapy with cetuximab: the CELIM randomised phase 2 trial. Lancet Oncol 11:38-47
18. Beppu T, Hayashi N, Masuda T et al (2010) FOLFOX enables high resectability and excellent prognosis for initially unresectable colorectal liver metastases. Anticancer Res 30:1015-1020
19. Elias D, De Baere T, Smayra T et al (2002) Percutaneous radiofrequency thermoablation as an alternative to surgery for treatment of liver tumour recurrence after hepatectomy. Br J Surg 89:752-756
20. Oshowo A, Gillams A, Harrison E et al (2003) Comparison of resection and radiofrequency ablation for treatment of solitary colorectal liver metastases. Br J Surg 90:1240-1243
21. Tait IS, Yong SM, Cuschieri SA (2002) Laparoscopic in situ ablation of liver cancer with cryotherapy and radiofrequency ablation. Br J Surg 89:1613-1619
22. Mima K, Beppu T, Masuda T et al (2011) The role of thermal ablation for colorectal liver metastases in the era of effective chemotherapy. Thermal Med 27:1-8
23. Wicherts DA, de Haas RJ, Adam R (2007) Bringing unresectable liver disease to resection with curative intent. Eur J Surg Oncol 33(Suppl 2):S42-S51
24. Kubota K, Makuuchi M, Kusaka K et al (1997) Measurement of liver volume and hepatic functional reserve as a guide to decision-making in resectional surgery for hepatic tumors. Hepatology 26:1176-1181
25. Imamura H, Seyama Y, Kokudo N, et al (2003) One thousand fifty-six hepatectomies without mortality in 8 years. Arch Surg 138:1198-1206 (discussion 1206)
26. Therasse P, Arbuck SG, Eisenhauer EA et al (2000) New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada. J Natl Cancer Inst 92:205-216
27. Japanese Society for Cancer of the Colon and Rectum (2009) Japanese classification of colorectal carcinoma. 2nd English ed. Kanehara Shuppan, Tokyo
28. Beppu T, Ishiko T, Masuda T et al (2007) Endoscopic Local Ablation Therapy (ELAT) for hepatocellular carcinoma. Thermal Med 23:63-70
29. Masuda T, Beppu T, Ishiko T, et al (2007) Thermal ablation using Microwave Coagulation Therapy (MCT) and Radiofrequency Ablation (RFA) for hepatocellular carcinoma. Thermal Med 23:123-131
30. Dodd GD 3rd, Frank MS, Aribandi M et al (2001) Radiofrequency thermal ablation: computer analysis of the size of the thermal injury created by overlapping ablations. Am J Roentgenol 177:777-782
31. Dindo D, Demartines N, Clavien PA (2004) Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg 240:205-213
32. Clavien PA, Barkun J, de Oliveira ML et al (2009) The Clavien-Dindo classification of surgical complications: five-year experience. Ann Surg 250:187-196
33. Paugam-Burtz C, Janny S, Delefosse D et al (2009) Prospective validation of the "fifty-fifty" criteria as an early and accurate predictor of death after liver resection in intensive care unit patients. Ann Surg 249:124-128
34. Wong SL, Mangu PB, Choti MA et al (2010) American Society of Clinical Oncology 2009 clinical evidence review on radiofrequency ablation of hepatic metastases from colorectal cancer. J Clin Oncol 28:493-508
35. Nicoli N, Casaril A, Abu Hilal M et al (2004) A case of rapid intrahepatic dissemination of hepatocellular carcinoma after radiofrequency thermal ablation. Am J Surg 188:165-167
36. Nikfarjam M, Shereef S, Kimchi ET et al (2009) Survival outcomes of patients with colorectal liver metastases following hepatic resection or ablation in the era of effective chemotherapy. Ann Surg Oncol 16:1860-1867
37. Leung EY, Roxburgh CS, Leen E et al (2010) Combined resection and radiofrequency ablation for bilobar colorectal cancer liver metastases. Hepatogastroenterology 57:41-46